SG10201604656YA - Kinase inhibitors - Google Patents
Kinase inhibitorsInfo
- Publication number
- SG10201604656YA SG10201604656YA SG10201604656YA SG10201604656YA SG10201604656YA SG 10201604656Y A SG10201604656Y A SG 10201604656YA SG 10201604656Y A SG10201604656Y A SG 10201604656YA SG 10201604656Y A SG10201604656Y A SG 10201604656YA SG 10201604656Y A SG10201604656Y A SG 10201604656YA
- Authority
- SG
- Singapore
- Prior art keywords
- kinase inhibitors
- kinase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11192894 | 2011-12-09 | ||
| EP12187932 | 2012-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201604656YA true SG10201604656YA (en) | 2016-07-28 |
Family
ID=47469888
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201402986RA SG11201402986RA (en) | 2011-12-09 | 2012-12-05 | Kinase inhibitors |
| SG10201604656YA SG10201604656YA (en) | 2011-12-09 | 2012-12-05 | Kinase inhibitors |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201402986RA SG11201402986RA (en) | 2011-12-09 | 2012-12-05 | Kinase inhibitors |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8835431B2 (en) |
| EP (1) | EP2788348B1 (en) |
| JP (1) | JP6145849B2 (en) |
| KR (1) | KR20140105459A (en) |
| CN (1) | CN103974953B (en) |
| AR (1) | AR089113A1 (en) |
| AU (1) | AU2012347352B2 (en) |
| BR (1) | BR112014013177A2 (en) |
| CA (1) | CA2860479A1 (en) |
| HK (1) | HK1199873A1 (en) |
| IL (1) | IL232959A (en) |
| MX (1) | MX351958B (en) |
| MY (1) | MY167216A (en) |
| PH (1) | PH12014501278A1 (en) |
| RU (1) | RU2623734C9 (en) |
| SG (2) | SG11201402986RA (en) |
| TW (1) | TWI568732B (en) |
| WO (1) | WO2013083606A1 (en) |
| ZA (1) | ZA201404157B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103974953B (en) * | 2011-12-09 | 2016-06-29 | 奇斯药制品公司 | Inhibitors of kinases |
| US9458154B2 (en) * | 2011-12-09 | 2016-10-04 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
| KR101994381B1 (en) | 2011-12-09 | 2019-06-28 | 키에시 파르마슈티시 엣스. 피. 에이. | Kinase inhibitors |
| BR112015029970A2 (en) * | 2013-06-06 | 2017-07-25 | Chiesi Farm Spa | kinase inhibitors |
| TW201730189A (en) * | 2015-12-23 | 2017-09-01 | 吉斯藥品公司 | Kinase inhibitors |
| US10364245B2 (en) * | 2017-06-07 | 2019-07-30 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| CN114732910A (en) | 2017-10-05 | 2022-07-12 | 弗尔康医疗公司 | P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD |
| CN108424372B (en) * | 2018-05-11 | 2021-08-10 | 浙江华贝药业有限责任公司 | Process for purifying 2, 2, 2-trifluoro-N- [ (S) -4-carbonyltetrahydronaphthalen-1-yl ] -acetamide |
| RU2676692C1 (en) * | 2018-08-01 | 2019-01-10 | Российская Федерация, От Имени Которой Выступает Министерство Промышленности И Торговли Российской Федерации | Method of producing n-phenyl-2-naftylamine |
| JP7333062B2 (en) | 2019-10-31 | 2023-08-24 | 株式会社タカゾノ | winding body |
| JP7323926B2 (en) | 2019-10-31 | 2023-08-09 | 株式会社タカゾノ | winding body |
| JP7301362B2 (en) | 2019-10-31 | 2023-07-03 | 株式会社タカゾノ | Core body |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
| AU6311996A (en) | 1995-07-06 | 1997-02-05 | Zeneca Limited | Peptide inhibitors of fibronectine |
| US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
| YU25500A (en) | 1999-05-11 | 2003-08-29 | Pfizer Products Inc. | Process for the synthesis of nucleosite analogues |
| CA2374737C (en) | 1999-07-09 | 2008-02-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Novel process for synthesis of heteroaryl-substituted urea compounds |
| GB0028383D0 (en) | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| EP1241176A1 (en) | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Purine derivatives for the treatment of ischemia |
| JP4486817B2 (en) | 2001-12-20 | 2010-06-23 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 1,4-dihydro-1,4-diphenylpyridine derivative |
| JP2006517580A (en) * | 2003-02-14 | 2006-07-27 | ファイザー・プロダクツ・インク | Triazolopyridine as an anti-inflammatory compound |
| WO2004078116A2 (en) * | 2003-03-03 | 2004-09-16 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| CN1838958A (en) * | 2003-08-22 | 2006-09-27 | 贝林格尔·英格海姆药物公司 | Methods of treating COPD and pulmonary hypertension |
| SE0302487D0 (en) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| EP1609789A1 (en) | 2004-06-23 | 2005-12-28 | Eli Lilly And Company | Ureido-pyrazole derivatives and their use as kinase inhibitors |
| US7767674B2 (en) | 2004-06-23 | 2010-08-03 | Eli Lilly And Company | Kinase inhibitors |
| JP4084836B2 (en) | 2004-08-12 | 2008-04-30 | ファイザー・インク | Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors |
| BRPI0514391A (en) | 2004-08-18 | 2008-06-10 | Pharmacia & Upjohn Co Llc | triazolopyridine compounds for the treatment of inflammation |
| AU2005321946B2 (en) | 2004-12-23 | 2012-08-16 | Deciphera Pharmaceuticals, Llc | Enzyme modulators and treatments |
| GB0502258D0 (en) | 2005-02-03 | 2005-03-09 | Argenta Discovery Ltd | Compounds and their use |
| EP1891047A4 (en) | 2005-06-03 | 2008-07-09 | Bayer Healthcare Ag | 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents |
| JP2009526037A (en) * | 2006-02-09 | 2009-07-16 | ファイザー・リミテッド | Triazolopyridine compound |
| US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| US7897762B2 (en) | 2006-09-14 | 2011-03-01 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of proliferative diseases |
| AR063141A1 (en) | 2006-10-04 | 2008-12-30 | Pharmacopeia Inc | DERIVATIVES OF 2- (BENZIMIDAZOLIL) PURINA 8- REPLACED FOR IMMUNOSUPPRESSION |
| EP2068869A4 (en) | 2006-10-06 | 2011-05-25 | Abbott Lab | Novel imidazothiazoles and imidazoxazoles |
| ES2320955B1 (en) * | 2007-03-02 | 2010-03-16 | Laboratorios Almirall S.A. | NEW DERIVATIVES OF 3 - ((1,2,4) TRIAZOLO (4,3-A) PIRIDIN-7-IL) BENZAMIDA. |
| CN101636397B (en) | 2007-04-13 | 2012-06-13 | 中国人民解放军军事医学科学院毒物药物研究所 | Urea compounds, preparation methods and pharmaceutical uses thereof |
| EP2177505A4 (en) | 2007-08-10 | 2011-08-31 | Astellas Pharma Inc | Bicyclic acylguanidine derivative |
| WO2009048474A1 (en) | 2007-10-12 | 2009-04-16 | Pharmacopeia, Inc. | 2,7,9-substituted purinone derivatives for immunosuppression |
| WO2009150614A1 (en) | 2008-06-11 | 2009-12-17 | Actelion Pharmaceuticals Ltd | Tetrazole compounds as orexin receptor antagonists |
| TWI496779B (en) | 2008-08-19 | 2015-08-21 | Array Biopharma Inc | Triazolopyridine compounds as pim kinase inhibitors |
| MX2011006094A (en) | 2008-12-08 | 2011-11-29 | Gilead Connecticut Inc | Imidazopyrazine syk inhibitors. |
| EP2384320B1 (en) | 2009-01-05 | 2015-03-04 | Boehringer Ingelheim International GmbH | Pyrrolidine compounds which modulate the cb2 receptor |
| EA201190119A1 (en) * | 2009-02-17 | 2012-05-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | DERIVATIVES OF TRIAZOLOPIRIDINE AS MAR-KINASE INHIBITORS p38 |
| US9127016B2 (en) | 2009-03-20 | 2015-09-08 | University of Pittsburgh—of the Commonwealth System of Higher Education | Small molecule inhibitors of Dusp6 and uses therefor |
| US8721380B2 (en) | 2009-08-12 | 2014-05-13 | Konica Minolta Holdings, Inc. | Method for manufacturing display panel |
| EP2308866A1 (en) | 2009-10-09 | 2011-04-13 | Bayer CropScience AG | Phenylpyri(mi)dinylpyrazoles and their use as fungicides |
| GB0921731D0 (en) | 2009-12-11 | 2010-01-27 | Respivert Ltd | Theraputic uses |
| GB201005589D0 (en) * | 2010-04-01 | 2010-05-19 | Respivert Ltd | Novel compounds |
| EP2556068B1 (en) * | 2010-04-08 | 2019-01-23 | Respivert Limited | P38 map kinase inhibitors |
| GB201009731D0 (en) * | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
| CN103974953B (en) * | 2011-12-09 | 2016-06-29 | 奇斯药制品公司 | Inhibitors of kinases |
| US9458154B2 (en) * | 2011-12-09 | 2016-10-04 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
| KR101994381B1 (en) * | 2011-12-09 | 2019-06-28 | 키에시 파르마슈티시 엣스. 피. 에이. | Kinase inhibitors |
-
2012
- 2012-12-05 CN CN201280060504.1A patent/CN103974953B/en not_active Expired - Fee Related
- 2012-12-05 BR BR112014013177A patent/BR112014013177A2/en not_active IP Right Cessation
- 2012-12-05 WO PCT/EP2012/074450 patent/WO2013083606A1/en active Application Filing
- 2012-12-05 KR KR1020147015414A patent/KR20140105459A/en not_active Application Discontinuation
- 2012-12-05 CA CA2860479A patent/CA2860479A1/en not_active Abandoned
- 2012-12-05 MX MX2014006629A patent/MX351958B/en active IP Right Grant
- 2012-12-05 RU RU2014123031A patent/RU2623734C9/en not_active IP Right Cessation
- 2012-12-05 EP EP12808706.1A patent/EP2788348B1/en active Active
- 2012-12-05 MY MYPI2014001671A patent/MY167216A/en unknown
- 2012-12-05 SG SG11201402986RA patent/SG11201402986RA/en unknown
- 2012-12-05 AU AU2012347352A patent/AU2012347352B2/en not_active Ceased
- 2012-12-05 JP JP2014545230A patent/JP6145849B2/en not_active Expired - Fee Related
- 2012-12-05 SG SG10201604656YA patent/SG10201604656YA/en unknown
- 2012-12-07 AR ARP120104597A patent/AR089113A1/en unknown
- 2012-12-07 TW TW101146029A patent/TWI568732B/en not_active IP Right Cessation
- 2012-12-07 US US13/708,191 patent/US8835431B2/en not_active Expired - Fee Related
-
2014
- 2014-06-05 IL IL232959A patent/IL232959A/en not_active IP Right Cessation
- 2014-06-06 ZA ZA2014/04157A patent/ZA201404157B/en unknown
- 2014-06-06 PH PH12014501278A patent/PH12014501278A1/en unknown
- 2014-08-05 US US14/451,600 patent/US9029373B2/en not_active Expired - Fee Related
-
2015
- 2015-01-07 HK HK15100163.4A patent/HK1199873A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2014123031A (en) | 2016-01-27 |
| AR089113A1 (en) | 2014-07-30 |
| BR112014013177A2 (en) | 2017-06-13 |
| TWI568732B (en) | 2017-02-01 |
| JP2015502948A (en) | 2015-01-29 |
| EP2788348B1 (en) | 2016-10-19 |
| PH12014501278B1 (en) | 2014-09-08 |
| US20130150361A1 (en) | 2013-06-13 |
| MY167216A (en) | 2018-08-14 |
| US9029373B2 (en) | 2015-05-12 |
| EP2788348A1 (en) | 2014-10-15 |
| WO2013083606A1 (en) | 2013-06-13 |
| JP6145849B2 (en) | 2017-06-14 |
| RU2623734C2 (en) | 2017-06-29 |
| TW201331200A (en) | 2013-08-01 |
| HK1199873A1 (en) | 2015-07-24 |
| CN103974953A (en) | 2014-08-06 |
| MX351958B (en) | 2017-11-06 |
| ZA201404157B (en) | 2015-12-23 |
| PH12014501278A1 (en) | 2014-09-08 |
| SG11201402986RA (en) | 2014-12-30 |
| KR20140105459A (en) | 2014-09-01 |
| US20140343055A1 (en) | 2014-11-20 |
| IL232959A (en) | 2016-11-30 |
| MX2014006629A (en) | 2014-07-09 |
| IL232959A0 (en) | 2014-08-03 |
| AU2012347352B2 (en) | 2016-12-15 |
| RU2623734C9 (en) | 2017-09-18 |
| US8835431B2 (en) | 2014-09-16 |
| CA2860479A1 (en) | 2013-06-13 |
| CN103974953B (en) | 2016-06-29 |
| AU2012347352A1 (en) | 2014-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1222647A1 (en) | Kinase inhibitors | |
| HUE048834T2 (en) | Kinase inhibitors | |
| HK1200451A1 (en) | Protein kinase inhibitors | |
| IL228103A0 (en) | Amino-quinolines as kinase inhibitors | |
| EP2683693A4 (en) | Rorgammat inhibitors | |
| SI2710005T1 (en) | Tyrosine kinase inhibitors | |
| EP2694517A4 (en) | Protein kinase inhibitors | |
| EP2782580A4 (en) | Selective kinase inhibitors | |
| IL229028A0 (en) | Kinase inhibitors | |
| HK1199873A1 (en) | Kinase inhibitors | |
| GB201009731D0 (en) | Kinase inhibitors | |
| ZA201306855B (en) | Protein kinase inhibitors | |
| EP2685992A4 (en) | Amino-quinolines as kinase inhibitors | |
| IL232234A0 (en) | Aminopyrimidine kinase inhibitors | |
| IL228928A0 (en) | Aminopyrimidine kinase inhibitors | |
| GB201120474D0 (en) | Inhibitors |